Safety, tolerability, and efficacy of an in‐class combination therapy switch from bosentan plus sildenafil to ambrisentan plus tadalafil in children with pulmonary arterial hypertension

Abstract The aim of this single‐centre retrospective observational study was to evaluate the safety, tolerability, and efficacy of an in‐class combination therapy switch from bosentan plus sildenafil to ambrisentan plus tadalafil in children with pulmonary arterial hypertension. Children aged over 5...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Cara Morgan, Nikmah Idris, Kathy Elterefi, Luca Di Ienno, Andrew Constantine, Sadia Quyam, Roberta Bini, Shahin Moledina
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Wiley 2024-10-01
Seri Bilgileri:	Pulmonary Circulation
Konular:	pulmonary artery hypertension pulmonary hypertension rare pediatric lung disease treatment
Online Erişim:	https://doi.org/10.1002/pul2.70011
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!